📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Rexahn Pharmaceuticals

1.1 - Company Overview

Rexahn Pharmaceuticals Logo

Rexahn Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Rexahn Pharmaceuticals

Merck Logo

Merck

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and vaccines for various diseases, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Merck company profile →
HRA Pharma Logo

HRA Pharma

HQ: France Website
  • Description: Provider of drugs, devices, and services in reproductive health and endocrine diseases, offering products such as Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for hormone replacement therapy; and GyMiso for cervical ripening.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HRA Pharma company profile →
ViroPharma Logo

ViroPharma

HQ: United States Website
  • Description: Provider of biopharmaceutical products addressing serious diseases, focused on therapies used by physician specialists or in hospital settings; develops and commercializes treatments, with two marketed products and three development programs, including Vancocin HCl capsules.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViroPharma company profile →
Biosplice Logo

Biosplice

HQ: United States Website
  • Description: Provider of therapeutic solutions and clinical trials for tissue-level regeneration, developing therapies that modulate alternative splicing via CLK/DYRK kinase inhibition to treat diseases like osteoarthritis and cancer. Offerings include Lorecivivint, an injectable small molecule for knee osteoarthritis to reduce pain, improve function, and protect cartilage, with trials evaluating safety, efficacy, and dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biosplice company profile →
Synaptogenix Logo

Synaptogenix

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies in development for neurodegenerative diseases, using bryostatin to promote neuronal health and synaptic regeneration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synaptogenix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Rexahn Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Rexahn Pharmaceuticals

2.2 - Growth funds investing in similar companies to Rexahn Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Rexahn Pharmaceuticals

4.2 - Public trading comparable groups for Rexahn Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Rexahn Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Rexahn Pharmaceuticals

What does Rexahn Pharmaceuticals do?

Rexahn Pharmaceuticals is a provider of treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

Who are Rexahn Pharmaceuticals's competitors?

Rexahn Pharmaceuticals's competitors and similar companies include Merck, HRA Pharma, ViroPharma, Biosplice, and Synaptogenix.

Where is Rexahn Pharmaceuticals headquartered?

Rexahn Pharmaceuticals is headquartered in United States.

How many employees does Rexahn Pharmaceuticals have?

Rexahn Pharmaceuticals has 1,000 employees 🔒.

When was Rexahn Pharmaceuticals founded?

Rexahn Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Rexahn Pharmaceuticals in?

Rexahn Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Rexahn Pharmaceuticals

Who are the top strategic acquirers in Rexahn Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Rexahn Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Rexahn Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Rexahn Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Rexahn Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Rexahn Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Rexahn Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Rexahn Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Rexahn Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Rexahn Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Rexahn Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Rexahn Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Rexahn Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Rexahn Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Rexahn Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Rexahn Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Rexahn Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Rexahn Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Rexahn Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Rexahn Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Rexahn Pharmaceuticals